Prostate News and Research

RSS

Radiation therapy combo cures prostate cancer long-term

Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released in the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO.

7 Jan 2007

Men who father only daughters have a higher risk of prostate cancer

In a new and unique study to determine if genes on the Y chromosome are involved in prostate cancer, researchers at Columbia University's Mailman School of Public Health in conjunction with Hebrew University of Jerusalem found that men who had only daughters had a higher risk of prostate cancer than men who had at least one son, thus signifying a possible defect on the father's Y chromosome.

3 Jan 2007

Medium-sized polyps yield significant number of advanced adenomas and cancer

According to a University of Pittsburgh-led study published in the December issue of Gastroenterology, medium-sized polyps found in the colon with flexible sigmoidoscopy and subsequently evaluated by full colonoscopy are associated with a significant number of advanced adenomas (high-risk polyps) and cancers.

2 Dec 2006

Testosterone replacement therapy appears to be safe - has little effect on the prostate gland

Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association.

14 Nov 2006

Food can have an impact in preventing cancer

With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.

14 Nov 2006

New gold standard of care for overactive bladder

A major clinical trial finds that a combination of two common medications -- tolterodine (Detrol LA) and tamsulosin (Flomax) -- works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).

14 Nov 2006

Link between common lifestyle factors, immune system and cancer

The immune system is fickle, and easily influenced by more than just viruses and bacteria. It can be swayed by the seemingly unexpected, such as by what we eat, for example, and affected by surprising sources.

13 Nov 2006

Muscle protein myosin VI involved in the development of prostate cancer

Researchers at the Johns Hopkins Kimmel Cancer Center have for the first time implicated the muscle protein myosin VI in the development of prostate cancer and its spread.

8 Nov 2006

Scientists discover how androgen plays a role in the development of prostate cancer

Scientists have discovered for the first time a specific biochemical pathway by which the sex hormone, androgen, increases levels of harmful chemicals called reactive oxygen species (ROS) in the prostate gland that play a role in the development of prostate cancer.

8 Nov 2006

New research could affect future treatment options for prostate cancer

Two new studies on the treatment of prostate cancer could well affect future treatment options for patients.

8 Nov 2006

Anabolic steroids and antisocial behaviour go together

Swedish researchers have found that there could well be a link between the use of anabolic steroids and antisocial behaviour.

7 Nov 2006

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

Though researchers have made substantial progress in developing drug-ferrying nanoparticles that successfully target tumor cells in living animals, including humans, investigators have only now started the detailed work needed to identify formulation parameters that would optimize drug delivery to malignant cells.

6 Nov 2006

PSA blood tests for prostate cancer should start earlier in life

A study has found that measuring prostate specific antigen (PSA) in the blood may be the best way of identifying men with life-threatening prostate cancer.

2 Nov 2006

Racial disparities in preventive health care persist

The racial gap in preventive health care -- such as Pap tests, mammograms, and prostate and colorectal cancer screenings -- persists and might be larger than previously thought, a study published online in BMC Heath Services Research finds, the Washington Post reports.

17 Oct 2006

Lower PSA in obese men could be a warning

Researchers in the U.S. say that obese men have lower levels of a protein used to screen for prostate cancer risk, and doctors should take weight into account when determining a man's risk.

10 Oct 2006

No link between alcohol and prostate cancer risk

According to a new study drinking alcohol does not appear to up the risk of prostate cancer and men who drink alcohol may have a lower risk of having an aggressive prostate cancer and dying from the cancer.

2 Oct 2006

New drug gives hope to lung cancer victims

More people die from lung cancer than any other type of cancer and the prognosis for the disease is poor.

28 Sep 2006

Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers

In an attempt to increase the sensitivity of cancer biomarker detection and to decrease the need for large samples from which to detect those molecules, a multi-institutional research team has shown that a "forest" of single-walled carbon nanotubes can be used to detect lower levels of the prostate specific antigen (PSA) than is possible using the current commercial assay.

25 Sep 2006

Curcumin useful in the fight against colorectal cancer

Looking for a cancer cure? Try the spice rack. In the last few years, that tactic has proved productive for researchers investigating turmeric, a curry spice used for centuries in Indian traditional medicine.

19 Sep 2006

Black women living in South Carolina are more likely to develop cancers

Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.

18 Sep 2006